Published in N Engl J Med on December 05, 1996
A proposal to restructure hospital care for dying patients. N Engl J Med (1996) 5.26
The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution. Can Med Assoc J (1976) 4.65
The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med (1995) 3.39
Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med (1997) 3.31
Use of the Brompton mixture in treating the chronic pain of malignant disease. Can Med Assoc J (1976) 3.24
The Brompton mixture: effects on pain in cancer patients. Can Med Assoc J (1976) 2.36
The Brompton mixture versus morphine solution given orally: effects on pain. Can Med Assoc J (1979) 2.23
Living with the dying: use of the technique of participant observation. Can Med Assoc J (1976) 1.69
Death and dying: attitudes in a teaching hospital. Urology (1974) 1.59
Dealing with our losses. J Clin Oncol (1986) 1.56
Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer (1996) 1.52
Palliative care--a passing fad? Understanding and responding to the signs of the times. J Palliat Care (1994) 1.28
International group issues proposal for standards for care of terminally ill. Can Med Assoc J (1979) 1.22
Changes in quality of life following admission to palliative care units. Palliat Med (2001) 1.18
Living with cancer: "good" days and "bad" days--what produces them? Can the McGill quality of life questionnaire distinguish between them? Cancer (2000) 1.08
Ethical issues in palliative care research revisited. Palliat Med (1995) 0.96
The management of intractable pain in patients with advanced malignant disease. J Urol (1978) 0.96
Quality of life in HIV disease as measured by the McGill quality of life questionnaire. AIDS (1996) 0.91
Whither hospice evaluation. J Chronic Dis (1983) 0.91
Quality of life in terminal illness: defining and measuring subjective well-being in the dying. J Palliat Care (1992) 0.90
Well-being at the end of life: Part 1. A research agenda for psychosocial and spiritual aspects of care from the patient's perspective. Cancer Prev Control (1997) 0.86
The need for specialized training programs in palliative medicine. CMAJ (1997) 0.85
Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients. Cancer (1989) 0.81
A technique of urethrectomy in the male. Surg Gynecol Obstet (1970) 0.81
Defining quality of life. Eur J Cancer (1996) 0.80
Phototherapy in the treatment of depression in the terminally ill. J Pain Symptom Manage (1994) 0.77
Lymphography in germinal tumours of the testis. Br J Urol (1972) 0.77
Embryonal adenocarcinoma in the prepubertal testis. A clinicopathologic study of 18 cases. Cancer (1970) 0.76
The prophylaxis of nonindustrial urothelial tumours. Can Med Assoc J (1973) 0.75
Caring in today's health care system. Can Med Assoc J (1978) 0.75
Hospice care. J R Soc Med (1980) 0.75
Guidelines for legalized euthanasia in Canada. Ann R Coll Physicians Surg Can (1999) 0.75
Music therapy in palliative care. Can Med Assoc J (1979) 0.75
Spirituality, religion, and health: a critical appraisal of the Larson reports. Ann R Coll Physicians Surg Can (2002) 0.75
Relief of chronic pain. Can Med Assoc J (1979) 0.75
The management of intractable pain in patients with advanced malignant disease. Trans Am Assoc Genitourin Surg (1977) 0.75
Retroperitoneal angiomyosarcoma: a case report. J Urol (1971) 0.75
Keeping the mission. Am J Hosp Palliat Care (1993) 0.75
Psychological impact of urologic cancer. Cancer (1980) 0.75
Well-being at the end of life: Part 2. A research agenda for the delivery of care from the patient's perspective. Cancer Prev Control (1997) 0.75
Medical applications of heroin. Can Med Assoc J (1979) 0.75
The effect of chemotherapy on germinal testicular tumors in mice. Cancer (1970) 0.75
Carcinoma in situ of the bladder with associated prostatic involvement. J Urol (1974) 0.75
Living with the dying. Can Med Assoc J (1977) 0.75
Lymphadenectomy for testicular carcinoma. Can J Surg (1982) 0.75
Leydig cell tumors of testis including cryptorchid testis. N Y State J Med (1972) 0.75
ICRF-159 in treatment of germinal testicular tumor in animals. Urology (1974) 0.75
Cytologic diagnosis of renal-cell carcinoma. Reassessment of fat-soluble staining. Urology (1973) 0.75
Transvesical ureterocelography with endoscopic control. Br J Urol (1972) 0.75
Challenges in palliative care. Am J Hosp Care (1986) 0.75
Palliative medicine and modern technology. CMAJ (1999) 0.75
The early natural history of murine germinal testicular tumors. J Urol (1971) 0.75
Ureteral implantation into ileal conduits. J Urol (1968) 0.75
The ultimate meaning. Can Doct (1986) 0.75
Montreal (1975)--the Royal Victoria Hospital Palliative Care Service. Death Educ (1978) 0.75
Preoperative irradiation and radical cystectomy for bladder cancer. Urology (1973) 0.75
Hospice care and geriatric medicine. J R Soc Med (1980) 0.75
[What is terminal palliative care?]. Rev Prat (1986) 0.75
A re-examination of the renal blastema graft model for Wilms tumor production. J Urol (1974) 0.75